Neurocrine Biosciences Inc. Equity-NMS: NBIX

Healthcare

Drug Manufacturers - Specialty & Generic

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$102.88
Open :$99.4
Today's high :$100.52
Today's low :$93.59
52W low :$93.59
52W high :$157.9799
EPS(TTM): :3.29
Shares O/S :99.7 M
Market cap :9.54 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Neurocrine Biosciences Inc. $95.65 -5.68% 31.27 9.54B

Frequently Asked Questions

What is the share price of Neurocrine Biosciences Inc. today?

Neurocrine Biosciences Inc. (NBIX) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Neurocrine Biosciences Inc.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa, and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.